Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta. General Subjects|March 25, 2018
The NC domain of HIV-1 Gag contributes to the interaction of Gag with TSG101Salah Edin El Meshri, Emmanuel Boutant, Assia Mouhand, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2017
Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patientsAlicja Puszkiel, Gaëlle Noé, Pascaline Boudou-Rouquette, et al.
European Journal of Clinical Pharmacology|March 23, 2023
Predictive factors associated with pemetrexed acute toxicityMathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, et al.
Oncotarget|September 3, 2016
Clinical and kinomic analysis identifies peripheral blood mononuclear cells as a potential pharmacodynamic biomarker in metastatic renal cell carcinoma patients treated with sunitinibGaёlle Noé, Audrey Bellesoeur, Audrey Thomas-Schoemann, et al.
Cancers|June 5, 2019
Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with NivolumabGaëlle Noé, Audrey Bellesoeur, Lisa Golmard, et al.
Biomaterials|February 14, 2015
Biocompatible photoresistant far-red emitting, fluorescent polymer probes, with near-infrared two-photon absorption, for living cell and zebrafish embryo imagingSalim Adjili, Arnaud Favier, Guillaume Fargier, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 27, 2015
Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenibCamille Tlemsani, Olivier Huillard, Jennifer Arrondeau, et al.
Expert Opinion on Drug Safety|April 4, 2014
Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patientsOlivier Huillard, Emilie Boissier, Benoit Blanchet, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2025
Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort studyGermain Perrin, Audrey Thomas-Schoemann, François Goldwasser, et al.
Expert Opinion on Investigational Drugs|January 21, 2015
Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeuticsJennifer Arrondeau, Olivier Huillard, Camille Tlemsani, et al.
Pageof 8